Crush Research
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Crush Research between 13 Dec 2025 and 1 Jul 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Crush Research
Retatrutide
Tested 5 Samples
Last test 1 Jul 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Crush Research
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
1 Jul 2026
First
13 Dec 2025
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 1 Jul 2026 | View | 15mg | 17.2mg | 13.2mg | -23.3% | 99.90% | below LOQ | CRRT-15-0312-1 | White label / Silver crimp / White cap | Lab E | Public | |
| 16 Mar 2026 | View | 15mg | 15.3mg | 14.6mg | -4.4% | 99.70% | n/a | CRRT-15-0126-1 | (no data) | Lab G | Public | |
| 4 Mar 2026 | View | 15mg | 15.3mg | 11.9mg | -22.1% | 99.90% | n/a | CRRT-15-0126-01 | White Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 26 Jan 2026 | View | 30mg | 32.9mg | 33.6mg | +2.2% | 99.80% | n/a | CRRT -30-1025-01 | White Label / Silver Crimp / White Cap | Lab G | Public | |
| 13 Dec 2025 | View | 30mg | 32.3mg | 32mg | -0.9% | 99.70% | n/a | CRRT-30-1025-01 | White Label / Silver Crimp / White Cap | Lab G | Public | |